title: Con: heparin-bonded cardiopulmonary bypass circuits do not represent a desirable and cost-effective advance in cardiopulmonary bypass technology.
authors.affiliation: Department of Anaesthesia, University College London Hospitals, UK.
authors.forename: R L
authors.initials: RL
authors.lastname: Woolf
authors.forename: M G
authors.initials: MG
authors.lastname: Mythen
mesh_terms: D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D002315:Cardiopulmonary Bypass / Q000009:adverse effects / Q000191:economics / Q000295:instrumentation*; D003362:Cost-Benefit Analysis; D006493:Heparin / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans
chemical_list: D000925:Anticoagulants; D006493:Heparin